Eli Lilly and Company (LLY)
NYSE: LLY · Real-Time Price · USD
757.52
+17.45 (2.36%)
Aug 1, 2025, 10:38 AM - Market open
Eli Lilly and Company (LLY) Operating Expense Breakdown
History
| Date | Research and Development | Marketing, Selling, and Administrative | Acquired In-Process Research and Development | Impairment, Restructuring, and Other |
|---|---|---|---|---|
| Mar 31, 2025 | 11.20B | 9.11B | 4.74B | 895.60M |
| Dec 31, 2024 | 10.99B | 8.59B | 3.28B | 860.60M |
| Sep 30, 2024 | 10.53B | 8.09B | 3.71B | 523.37M |
| Jun 30, 2024 | 10.21B | 7.80B | 3.86B | 441.77M |
| Mar 31, 2024 | 9.85B | 7.61B | 3.81B | - |
| Dec 31, 2023 | 9.31B | 7.40B | 3.80B | 6.77M |
| Sep 30, 2023 | 8.75B | 7.12B | 3.42B | - |
| Jun 30, 2023 | 8.14B | 6.93B | 504.60M | - |
| Mar 31, 2023 | 7.57B | 6.63B | 847.90M | - |
| Dec 31, 2022 | 7.19B | 6.44B | 908.50M | 244.60M |
| Sep 30, 2022 | 7.15B | 6.39B | 1.11B | 311.00M |
| Jun 30, 2022 | 7.06B | 6.35B | 1.22B | - |
| Mar 31, 2022 | 6.95B | 6.41B | 823.70M | - |
| Dec 31, 2021 | 7.03B | 6.43B | 970.10M | 316.10M |
| Sep 30, 2021 | 6.90B | 6.39B | 898.70M | - |
| Jun 30, 2021 | 6.66B | 6.38B | 721.10M | - |
| Mar 31, 2021 | 6.38B | 6.15B | 920.10M | 282.90M |
| Dec 31, 2020 | 6.09B | 6.12B | 660.40M | 131.20M |
| Sep 30, 2020 | 5.83B | 6.27B | - | 313.00M |
| Jun 30, 2020 | 5.74B | 6.11B | 371.80M | - |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.